Altre lingue Aurobindo Pharma

Azioni

AUROPHARMA

INE406A01037

Tempo differito NSE India S.E. Altri mercati azionari 07:55:45 20/06/2024			Variaz. 5gg	Var. 1 gen.
1.236 ^INR	+1,17%		-1,51%	+13,99%

05/06	Novelis, di proprietà di Hindalco, ritarda l'IPO negli Stati Uniti; le azioni scivolano	RE
27/05	Aurobindo Pharma guadagna nell'utile netto consolidato del quarto trimestre fiscale	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hindalco-owned Novelis delays US IPO; shares slide	05/06
Aurobindo Pharma : receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray	31/05
Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit	27/05
Aurobindo Pharma : PR Q4 FY 2023 24	25/05
Aurobindo Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	25/05
Aurobindo Pharma : Q4FY24	17/05
India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	08/05
Aurobindo Pharma Limited Receives an Order from the Deputy Commissioner, Punjagutta Division, Hyderabad	02/05
Aurobindo Pharma Completes Sale of US Arm's Business Assets	02/05
Maintainability Of Sister Ship Arrest On The Premise That Both Vessels Are Managed/operated By The Same Entity, While Each Ship Is Owned By Distinct One Ship Company – Bombay High Court	29/04
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President R&D (Specialty Drug Delivery)	07/04
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India	02/04
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024	27/03
Indian shares set to track Asian peers higher, eye on Fed meet	20/03
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray	20/03
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration	19/03
Aurobindo Pharma Arm Restarts Distribution of Aseptic Products from Unit III	12/03
APL Healthcare Limited Subsidiary of Aurobindo Pharma Limited Announces Unit Inspection Team of World Health Organization Conducts an Inspection at the Unit IV	11/03
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer	05/03
Aurobindo Pharma Limited Receives USFDA Approval for Fingolimod Capsules, 0.5 Mg	01/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aurobindo Pharma

Azioni

AUROPHARMA

INE406A01037

Altre lingue

Filtri